The latest call
FetchingDermata Therapeutics, Inc. reported on 2026年11月10日. We are fetching the call transcript; its summary follows once the transcript is in.
US$0.59-16.9%11月13日 收盘
数据截至2026年9月30日,来自2026年11月10日提交的10-Q
Just reported
From Dermata Therapeutics, Inc.'s results release of 2026年11月10日; its quarterly report has since been filed.
Actual
US$74.1K
Guided
—
No guide given
Actual
-US$0.55
Guided
—
No guide given
Actual
-US$2.9M
Guided
—
No guide given
| 指标 | 截至该日的 3 个月2026年9月30日 | 截至该日的 3 个月2025年9月30日 | 变动 |
|---|---|---|---|
| 利润 | -US$2.8M | -US$1.7M | -66.75% |
| 每股收益 | -US$0.55 | -US$1.65 | +66.67% |
这些是单季度数字,不是滚动一年——本站其他地方的数字覆盖十二个月,会大得多。季节性业务在两者之间摆动很大:ServiceNow 在十二月季度赚 20 亿美元自由现金流,在六月季度只有 5 亿。
对比对象是去年同一季度,而不是分析师预测。要说“超预期”或“不及预期”需要一致预期数据,那是我们没有的授权数据——而搞错它比不提更糟。
Dermata Therapeutics, Inc. reported on 2026年11月10日. We are fetching the call transcript; its summary follows once the transcript is in.
公告在开盘前或收盘后发布,因此区间从公告日前一个交易日的收盘价到公告日之后那个交易日的收盘价——无论哪种情况,反应都包含在内。
Tome is Dermata’s skincare line focused on bringing about a new realm of skincare that is powerful, not punishing. Tome in its literal meaning is a large, important, scholarly book. Dermata intends to educate consumers with a brand that tells a skincare story rooted in science and history. Tome consists of skincare products utilizing a wild harvested freshwater sponge that has evolved over centuries for consumers compelled by history and science to find potent natural products for their skincare routine. Dermata believes its Tome skincare line can simplify existing skincare routines with essential ingredients designed to deliver results, without harmful extremes. Start your skincare story at Tome .
公司自己的描述,取自公告末尾。
引述和公司简介来自 Dermata Therapeutics, Inc. 于 2026年11月10日 提交的第 2.02 项 8-K 文件;表格根据其季度报告编制。 在 EDGAR 上阅读公告 股价已按拆股和分红复权。
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.